COVID-19 studies:  C19 studies: C19:  IvermectinIVM Vitamin DV.D HC QHC Q Vitamin CV.C ZincZn PVP-IPVP-I FLVFLV REGNR2 LY-CoVLY RemdesivirRMD

6/29 N/A
Mfeukeu-Kuate et al. (Preprint) (not included in the study count)
Electrocardiographic safety of daily Hydroxychloroquine 400mg plus Azithromycin 250mg as an ambulatory treatment for COVID-19 patients in Cameroon
Source   PDF   Share   Tweet
No life-threatening modifications of the QT interval was observed in non-severe COVID-19 patients treated ambulatory with HCQ+AZ. 51 relatively young patients 39 +/- 11.

Mfeukeu-Kuate et al., 6/29/2020, preprint, 29 authors.
Details of all 260 studies    Meta analysis
Please send us corrections, updates, or comments.
Submit